← FDA Drug Approvals (Drugs@FDA)

TRIMETHOBENZAMIDE HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BPI LABS · Approved 2025-10-16

Drug application

FDA Application #
ANDA219606
Application type
Abbreviated New Drug Application (Generic)
Brand name
TRIMETHOBENZAMIDE HYDROCHLORIDE
Generic name
Trimethobenzamide Hydrochloride
Active ingredients
TRIMETHOBENZAMIDE HYDROCHLORIDE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
BPI LABS
First approval
2025-10-16

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown